BORTEZOMIB FOR INJECTION

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: bbf582e8faf03c0e
Drug Approval Canada Name: BORTEZOMIB FOR INJECTION
Product Name: BORTEZOMIB FOR INJECTION
Status: Marketed
Status Date: 2020-05-19
Original Market Date: 2020-05-19
Din: 02493306
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Subcutaneous , Intravenous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XG01 BORTEZOMIB
Atc Name: l 01 xg 01
Aig Number: 0150433001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)

3.5 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bbf582e8faf03c0e

Type

Standard